Lemaitre Vascular (LMAT) Change in Receivables (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Change in Receivables data on file, last reported at $2.5 million in Q1 2026.

• Change in Receivables for Q1 2026 came in at $2.5 million, down 46.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $809000.0 (down 84.7% YoY), and the FY2025 annual result was $2.9 million, down 54.08% from the prior year.
• Change in Receivables rose to $2.5 million in Q1 2026 per LMAT's latest filing, from $1.5 million in the prior quarter.
• Over five years, Change in Receivables peaked at $5.8 million in Q1 2024 and troughed at -$3.9 million in Q3 2025.
• A 5-year average of $1.1 million and a median of $997000.0 in 2023 frame the typical range for Change in Receivables.
• The sharpest annual moves came in 2022 and 2025: Change in Receivables jumped 357.0% in 2022, then sank 513.59% in 2025.
• A 5-year view of Change in Receivables shows it stood at $1.8 million in 2022, then slumped by 41.09% to $1.1 million in 2023, then sank by 196.12% to -$1.0 million in 2024, then soared by 251.82% to $1.5 million in 2025, then surged by 60.69% to $2.5 million in 2026.
• Business Quant data shows LMAT's Change in Receivables at $2.5 million in Q1 2026, $1.5 million in Q4 2025, and -$3.9 million in Q3 2025.